HOXC6 and HOXC4 have been previously identified as promising, easy to assay (urinary-based) biomarkers of aggressive prostate cancer that can enhance early diagnosis and predict cancer recurrence after treatment [11–13]. This evidence concerns the gene HOXC4 and cancer.